← Eichor
Study identifier: NCT04370496 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION)

Condition: Cervical Cancer · Cervical Cancer Stage IB1 · Minimally Invasive Surgery  ·  Sponsor: Seoul National University Hospital

PhaseNA
Planned participants124
Who can joinFemale, 20 Years to no upper limit
Healthy volunteersNo

About this study

The SOLUTION trial aims to show the efficacy and safety of performing radical hysterectomy by minimally invasive surgery using an endoscopic stapler in patients with cervical cancer stage IB1 (FIGO staging 2009) and thus to prove that minimally invasive surgery is non-inferior to open surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Soo Jin Park, M.D.  ·  +82-02-2072-0897  ·  soojin.mdpark@gmail.com

Jaehee Mun, M.D.  ·  +82-02-2072-2388  ·  jhee1315@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Seoul National University HospitalSeoul, South KoreaRecruiting
Samsung Medical Center, Sungkyunkwan University School of MedicineSeoul, South KoreaRecruiting
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ajou University School of MedicineSuwon, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04370496